A randomized comparison of the efficacy and toxicity of epirubicin and doxorubicin in the treatment of patients with non-Hodgkin's lymphoma.
Nair, R
A randomized comparison of the efficacy and toxicity of epirubicin and doxorubicin in the treatment of patients with non-Hodgkin's lymphoma. [electronic resource] - Cancer Jun 1998 - 2282-8 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
0008-543X
10.1002/(sici)1097-0142(19980601)82:11<2282::aid-cncr26>3.0.co;2-p doi
Adolescent
Adult
Aged
Antibiotics, Antineoplastic--therapeutic use
Doxorubicin--adverse effects
Epirubicin--adverse effects
Female
Humans
Lymphoma, Non-Hodgkin--drug therapy
Male
Middle Aged
Recurrence
Survival Rate
A randomized comparison of the efficacy and toxicity of epirubicin and doxorubicin in the treatment of patients with non-Hodgkin's lymphoma. [electronic resource] - Cancer Jun 1998 - 2282-8 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
0008-543X
10.1002/(sici)1097-0142(19980601)82:11<2282::aid-cncr26>3.0.co;2-p doi
Adolescent
Adult
Aged
Antibiotics, Antineoplastic--therapeutic use
Doxorubicin--adverse effects
Epirubicin--adverse effects
Female
Humans
Lymphoma, Non-Hodgkin--drug therapy
Male
Middle Aged
Recurrence
Survival Rate